| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.31 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |